Design Therapeutics, Inc. reported the three months ended March 31, 2026 results: net income Net loss was $17.6 million for the quarter ended March 31, 2026..
“Net loss was $17.6 million for the quarter ended March 31, 2026.”
Design Therapeutics, Inc. — fact timeline
Source-grounded facts extracted from Design Therapeutics, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Design Therapeutics, Inc. reported the quarter ended March 31, 2024 results: net income $11.1 million.
“Net loss was $11.1 million for the quarter ended March 31, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.